For example, retinal laser photocoagulation therapy for DME can result in scotomas, reduced visual acuity and subretinal fibrosis [14], and anti-VEGFA therapies may lead to proteinuria, compounding kidney injury in those already at risk for DKD [58, 59]. Here, VEGFA is linked to diabetic kidney disease.